Pica Code: IPD-2026-008 Unveiling neutrophils' metabolism to set up a new therapy for non-small cell lung cancer. (omissis)
Posted on: 16/02/2026
Deadline: 03/03/2026
Scientific-Disciplinary Group
06/MEDS-02 - Experimental Medicine, Pathophysiology And Clinical Pathology
Description
The research activity will focus on the design, synthesis, and characterization of inhibitors of the receptors HCAR2/3 as potential antitumor agents. The final objective is the identification of molecules with high efficacy and selectivity, potentially applicable to the treatment of non-small cell lung cancer.
Compensation
28,456 Euro
Job posting website
Number of positions
1
Maximum duration
36.0
Funding body
UNIMORE
How to apply
Other
Selection process
Click to expand
public selection procedure based on qualifications and interview
View the original posting on the MUR website: Go to MUR website